27427386|t|Biochemical evidence for a mitochondrial genetic modifier in the phenotypic manifestation of Leber's hereditary optic neuropathy -associated mitochondrial DNA mutation
27427386|a|Leber's hereditary optic neuropathy (LHON) is the most common mitochondrial disease. Mitochondrial modifiers are proposed to modify the phenotypic expression of primary LHON -associated mitochondrial DNA (mtDNA) mutations. In this study, we demonstrated that the LHON susceptibility allele (m.14502T > C, p. 58I > V) in the ND6 gene modulated the phenotypic expression of primary LHON -associated m.11778G > A mutation. Twenty-two Han Chinese pedigrees carrying m.14502T > C and m.11778G > A mutations exhibited significantly higher penetrance of optic neuropathy than those carrying only m.11778G > A mutation. We performed functional assays using the cybrid cell models, generated by fusing mtDNA-less ρ(o) cells with enucleated cells from LHON patients carrying both m.11778G > A and m.14502T > C mutations, only m.14502T > C or m.11778G > A mutation and a control belonging to the same mtDNA haplogroup. These cybrids cell lines bearing m.14502T > C mutation exhibited mild effects on mitochondrial functions compared with those carrying only m.11778G > A mutation. However, more severe mitochondrial dysfunctions were observed in cell lines bearing both m.14502T > C and m.11778G > A mutations than those carrying only m.11778G > A or m.14502T > C mutation. In particular, the m.14502T > C mutation altered assemble of complex I, thereby aggravating the respiratory phenotypes associated with m.11778G > A mutation, resulted in a more defective complex I. Furthermore, more reductions in the levels of mitochondrial ATP and increasing production of reactive oxygen species were also observed in mutant cells bearing both m.14502T > C and m.11778G > A mutation than those carrying only 11778G > A mutation. Our findings provided new insights into the pathophysiology of LHON that were manifested by interaction between primary and secondary mtDNA mutations.
27427386	0	11	Biochemical	T169	C0205474
27427386	27	40	mitochondrial	T026	C0026237
27427386	41	48	genetic	T169	C0314603
27427386	49	57	modifier	T028	C3178895
27427386	65	75	phenotypic	T032	C0031437
27427386	76	89	manifestation	T169	C0205319
27427386	93	128	Leber's hereditary optic neuropathy	T047	C0917796
27427386	141	167	mitochondrial DNA mutation	T019	C0948444
27427386	168	203	Leber's hereditary optic neuropathy	T047	C0917796
27427386	205	209	LHON	T047	C0917796
27427386	230	251	mitochondrial disease	T047	C0751651
27427386	253	266	Mitochondrial	T026	C0026237
27427386	267	276	modifiers	T028	C3178895
27427386	304	325	phenotypic expression	T032	C0031437
27427386	337	341	LHON	T047	C0917796
27427386	354	371	mitochondrial DNA	T114,T123	C0012929
27427386	373	378	mtDNA	T114,T123	C0012929
27427386	380	389	mutations	T019	C0948444
27427386	399	404	study	T062	C2603343
27427386	431	435	LHON	T047	C0917796
27427386	436	450	susceptibility	T201	C0012655
27427386	451	457	allele	T028	C0002085
27427386	459	471	m.14502T > C	T028	C0002085
27427386	473	483	p. 58I > V	T028	C0002085
27427386	492	500	ND6 gene	T028	C1537995
27427386	501	510	modulated	T082	C0443264
27427386	515	536	phenotypic expression	T032	C0031437
27427386	548	552	LHON	T047	C0917796
27427386	565	586	m.11778G > A mutation	T045	C0026882
27427386	599	610	Han Chinese	UnknownType	C0814942
27427386	611	620	pedigrees	T170	C0030761
27427386	630	642	m.14502T > C	T045	C0026882
27427386	647	669	m.11778G > A mutations	T045	C0026882
27427386	701	711	penetrance	T081	C0524899
27427386	715	731	optic neuropathy	T047	C3887709
27427386	757	778	m.11778G > A mutation	T045	C0026882
27427386	793	803	functional	T169	C0205245
27427386	804	810	assays	T059	C0005507
27427386	821	839	cybrid cell models	T025	C0007600
27427386	861	882	mtDNA-less ρ(o) cells	T025	C0007634
27427386	888	904	enucleated cells	T025	C0007634
27427386	910	914	LHON	T047	C0917796
27427386	915	923	patients	T101	C0030705
27427386	938	950	m.11778G > A	T045	C0026882
27427386	955	977	m.14502T > C mutations	T045	C0026882
27427386	984	996	m.14502T > C	T045	C0026882
27427386	1000	1021	m.11778G > A mutation	T045	C0026882
27427386	1058	1063	mtDNA	T114,T123	C0012929
27427386	1064	1074	haplogroup	T032	C0018591
27427386	1082	1100	cybrids cell lines	T025	C0007600
27427386	1109	1130	m.14502T > C mutation	T045	C0026882
27427386	1146	1153	effects	T080	C1280500
27427386	1157	1170	mitochondrial	T026	C0026237
27427386	1171	1180	functions	T169	C0542341
27427386	1215	1236	m.11778G > A mutation	T045	C0026882
27427386	1259	1272	mitochondrial	T026	C0026237
27427386	1273	1285	dysfunctions	T077	C3887504
27427386	1303	1313	cell lines	T025	C0007600
27427386	1327	1339	m.14502T > C	T045	C0026882
27427386	1344	1366	m.11778G > A mutations	T045	C0026882
27427386	1392	1404	m.11778G > A	T045	C0026882
27427386	1408	1429	m.14502T > C mutation	T045	C0026882
27427386	1450	1471	m.14502T > C mutation	T045	C0026882
27427386	1492	1501	complex I	T116,T126	C0171406
27427386	1527	1538	respiratory	T169	C0521346
27427386	1539	1549	phenotypes	T032	C0031437
27427386	1566	1587	m.11778G > A mutation	T045	C0026882
27427386	1608	1617	defective	T169	C0332452
27427386	1618	1627	complex I	T116,T126	C0171406
27427386	1675	1688	mitochondrial	T026	C0026237
27427386	1689	1692	ATP	T114,T121,T123	C0001480
27427386	1722	1745	reactive oxygen species	T123,T196	C0162772
27427386	1768	1774	mutant	T049	C0596988
27427386	1775	1780	cells	T025	C0007634
27427386	1794	1806	m.14502T > C	T045	C0026882
27427386	1811	1832	m.11778G > A mutation	T045	C0026882
27427386	1858	1877	11778G > A mutation	T045	C0026882
27427386	1923	1938	pathophysiology	T169	C0031847
27427386	1942	1946	LHON	T047	C0917796
27427386	1957	1970	manifested by	T080	C1280444
27427386	2013	2018	mtDNA	T114,T123	C0012929
27427386	2019	2028	mutations	T019	C0948444